Brigatinib in patients with ALK-positive advanced non-small-cell lung cancer pretreated with sequential ALK inhibitors: A multicentric real-world study (BRIGALK study)

Autor: Descourt, Renaud, Perol, Maurice, Rousseau-Bussac, Gaëlle, Planchard, David, Mennecier, Bertrand, Wislez, Marie, Cortot, Alexis, Guisier, Florian, Galland, Loïck, Dô, Pascal, Schott, Roland, Dansin, Eric, Arrondeau, Jennifer, Auliac, Jean-Bernard, Chouaid, Christos
Zdroj: In Lung Cancer October 2019 136:109-114
Databáze: ScienceDirect
Externí odkaz: